The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug data with comprehensive drug target information.
The latest release of DrugBank (version 5.1.3, released 2019-04-02) contains 12,150 drug entries including 2,557 approved small molecule drugs, 1,286 approved biotech (protein/peptide) drugs, 130 nutraceuticals and over 5,867 experimental drugs. Additionally, 5,167 non-redundant protein (i.e. drug target/enzyme/transporter/carrier) sequences are linked to these drug entries. Each DrugCard entry contains more than 200 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data.
- OxycodoneFor the treatment of diarrhoea, pulmonary oedema and for the relief of moderate to moderately severe pain.
- SalbutamolSalbutamol is indicated for (i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm...
- AcetaminophenIn general, acetaminophen is used for the treatment of mild to moderate pain and reduction of fever. It is available over the counter in various forms, the most common being...
- MorphineMorphine is used for the management of chronic moderate-to-severe pain.Opioids, including morphine, can manage pain effectively when used for a short amount of time. The use of opioids for longer...
- Acetylsalicylic acidPain, fever, and inflammation Acetylsalicylic acid (ASA), in the regular tablet form (immediate-release), is indicated to relieve pain, fever, and inflammation associated with many conditions, including the flu, the common...
Ketamine is an NMDA receptor antagonist with a potent anesthetic effect.It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic effects. It was FDA approved in 1970, and from there, it has been used as an anesthetic for children or patients undergoing minor surgeries but mainly for veterinary purposes.
Cannabinoids in Epilepsy: A New Era of Treatments
From Discovery to Resistance to Progress
Ketamine: the key to treatment resistant depression?
Tideglusib: From Alzheimer's to Caries Lesion Natural Repair
CFTR Modulators Helping CF Patients Catch Their Breath
New Antivirals Provide Hope for Eradication of Hepatitis C – If You Can Afford It
DrugBank is offered to the public as a freely available resource.
Use and re-distribution of the data, in whole or in part, for commercial purposes (including internal use) requires a license. We ask that users who download significant portions of the database cite the DrugBank paper in any resulting publications.